References
- 1. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 2010; 127: 2893-917.
- 2. Cancer in Slovenia 2009. Ljubljana: Institute of Oncology Ljubljana, Epidemiology and Cancer Registry, Cancer Registry of Republic of Slovenia. 2013 [citated 2013 Nov 25]. Available from: http://www.onko-i.si/eng/crs.
- 3. Tepeš B, Kavalar R. [Gastric cancer, screening possibilities and proposals for endoscopic and histologic follow-up of premalignant gastric lesions]. [Slovenian]. Zdrav Vestn 2010; 79: 366-74.
- 4. Chandanos E, Lagergren J. Oestrogen and the enigmatic male predominance of gastric cancer. Eur J Cancer 2008; 44: 2397-403.
- 5. Kusters JG, van Vliet AHM, Kuipers EJ. Pathogenesis of Helicobacter pylori infection. Clin Microbiol Rev 2006; 19: 449-90.
- 6. Kodama M, Murakami K, Sato R, Okimoto T, Nishizono A, Fujioka T. Helicobacter pylori-infected animal models are extremely suitable for the investigation of gastric carcinogenesis. World J Gastroenterol 2005; 11: 7063-71.
- 7. Manxhuka-Kerliu S, Telaku S, Devolli-Disha E, Ahmetaj H, Sahatciu-Meka V, Kerliu A, et al. 2009. Helicobacter pylori gastritis updated Sydney classification applied in our material. Prilozi 2009; 30: 45-60.
- 8. Ishihara S, Rumi MA, Kadowaki Y, Ortega-Cava CF, Yuki T, Yoshino N, et al. Essential role of MD-2 in TLR4-dependent signaling during Helicobacter pylori-associated gastritis. J Immunol 2004; 173: 1406-16.
- 9. Lu W, Pan H, Zhang L, Lin D, Miao X, You W. Genetic polymorphisms of inter-leukin IL-1B, IL-1RN, IL-8, IL-10 and tumor necrosis factor α and risk of gastric cancer in a Chinese population. Carcinogenesis 2005; 26: 631-6.
- 10. Correa P, Haensze, W, Cuello C, Tannenbaum S, Archer M. A model for gastric cancer epidemiology. Lancet 1975; 2: 58-60.
- 11. Jorge YC, Duarte MC, Silva AE. Gastric cancer is associated with NOS2-954G/C polymorphism and environmental factors in a Brazilian population. BMC Gastroenterol 2010; 10: 64-84.
- 12. Murphy G, Thornton J, McManus R, Swan N, Ryan B, O’Morain CA, et al. Association of gastric disease with polymorphisms in the inflammatory related genes IL-1B, IL-1RN, IL-10, TNF and TLR4. Eur J Gastroenterol Hepatol 2009; 21: 630-5.
- 13. Melo Barbosa HP, Martins LC, Dos Santos SE, Demachki S, Assumpção MB, Aragão CD, et al. Interleukin-1 and TNF-α polymorphisms and Helicobacter pylori in a Brazilian Amazon population. World J Gastroenterol 2009; 15: 1465-71.
- 14. Kamangar F, Abnet CC, Hutchinson AA, Newschaffer CJ, Helzlsouer K, Shugart YY, et al. Polymorphisms in inflammation-related genes and risk of gastric cancer (Finland). Cancer Causes Control 2006; 17: 117-25.
- 15. Moorchung N, Srivastava AN, Gupta NK, Ghoshal UC, Achyut BR, Mittal B. 2007. Cytokine gene polymorphisms and the pathology of chronic gastritis. Singapore Med J 2007; 48: 447-54.
- 16. Skvarc M, Stubljar D, Kopitar AN, Jeverica S, Tepes B, Kos J, et al. Inhibition of cathepsin X enzyme influences the immune response of THP-1 cells and dendritic cells infected with Helicobacter pylori. Radiol Oncol 2013; 47: 258-65.
- 17. Ito H, Kaneko K, Makino R, Konishi K, Kurahashi T, Yamamoto T, et al. Interleukin-1beta gene in esophageal, gastric and colorectal carcinomas. Oncol Rep 2007; 18: 473-81.
- 18. Xue H, Lin B, Ni P, Xu H, Huang G. Interleukin-1B and interleukin-1 RN polymorphism and gastric carcinoma risk: A meta-analysis. J Gastroenterol Hepatol 2010; 25: 1604-17.
- 19. Sitarz R, de Leng WWJ, Polak M, Morsink FHM, Bakker O, Polkowski WP, et al. IL-1B −31T>C promoter polymorphism is associated with gastric stump cancer but not with early onset or conventional gastric cancers. Virchows Arch 2008; 453: 249-55.
- 20. El-Omar EM, Carrington M, Chow WH, McColl KEL, Breamk JH, Young H, et al. Interleukin-1 polymorphisms associated with increased risk of gastric cancer. Nature 2000; 404: 398-402.
- 21. Cauci S, Santolo MD, Ryckman KK, Williams SM, Banfi G. Variable number of tandem repeat polymorphism of the interleukin-1 receptor antagonist gene IL-1RN: a novel association with the athlete status. BMC Med Genet 2010; 11: 29-40.
- 22. Crusius JB, Canzian F, Capellá G, Peña AS, Pera G, Sala N, et al. Cytokine gene polymorphisms and the risk of adenocarcinoma of the stomach in the European prospective investigation into cancer and nutrition (EPIC-EURGAST). Ann Oncol 2008; 19: 1894-902.
- 23. Zambon CF, Basso D, Navaglia F, Belluco C, Falda A, Fogar P, et al. Pro- and anti-inflammatory cytokines gene polymorphisms and Helicobacter pylori infection: interactions influence outcome. Cytokine 2005; 29: 141-52.
- 24. Hou L, El-Omar EM, Chen J, Grillo P, Rabkin CS, Baccarelli A, et al. Polymorphisms in Th1-type cell-mediated response genes and risk of gastric cancer. Carcinogenesis 2007; 28: 118-23.
- 25. El-Omar EM, Rabkin CS, Marilie DG, Vaughan TL, Harvey AR, Schoenberg JB, et al. Increased risk of noncardia gastric cancer associated with proinflammatory cytokine gene polymorphisms. Gastroenterology 2003; 124: 1193-201.
- 26. Machado JC, Figueiredo C, Canedo P, Pharoah P, Carvalho R, Nabais S, et al. A proinflammatory genetic profile increases the risk for chronic atrophic gastritis and gastric carcinoma. Gastroenterology 2003; 125: 364-71.
- 27. Hold GL, Rabkin CS, Chow WH, Smith MG, Gammon MD, Risch HA, et al. A functional polymorphism of toll-like receptor 4 gene increases risk of gastric carcinoma and its precursors. Gastroenterology 2007; 132: 905-12.
- 28. Garza-Gonzalez E, Bosques-Padilla FJ, Mendoza-Ibarra SI, Flores-Gutierrez JP, Maldonado-Garza HJ, Perez-Perez GI. Assessment of the toll-like receptor Asp299Gly, Thr399Ile and interleukin-8 -25 I polymoprhisms in the risk for the development of distal gastric cancer. BMC Cancer 2007; 7: 70.
- 29. Hishida A, Matsuo K, Goto Y, Mitsuda Y, Hiraki A, Naito M, et al. Toll-like receptor 4 +3725 G/C polymorphism, Helicobacter pylori seropositivity, and the risk of gastric atrophy and gastric cancer in Japanese. Helicobater 2009; 14: 47-53.
- 30. Achyut BR, Ghoshal UC, Moorchung N, Mittal B. Association of toll-like receptor-4 (Asp299Gly and Thr399Ileu) gene polymorphisms with gastritis and precancerous lesions. Hum Immunol 2007; 68: 901-7.
- 31. El-Omar EM, Ng MT, Hold GL. Polymorphisms in Toll-like receptor genes and risk of cancer. Oncogene 2008; 27: 244-52.
- 32. Dixon MF, Genta R, Yardley JH, Correa P. Classification and grading of gastritis: The updated Sydney system. Am J Surg Pathol 1996; 20: 1161-81.
- 33. Szeto ML, Lee CK, Yee YK, Li K., Lee WK, Lee CC, et al. Evaluation of five commercial serological tests for the detection of Helicobacter pylori infection in Chinese. Aliment Pharmacol Ther 2001; 15: 703-6.
- 34. Kirchgesser M, Adem C, Baumgartner A, Girgnhuber H, Malmberg W, Schmitt I, et al. Automated isolation of DNA from tissue samples in 35-50 minutes: Fast and easy purification combining the MagNA Lyser and the MagNA Pure Compact System. Biochemica 2006; 1: 9-10.
- 35. Highet AR, Gibson CS, Goldwater PN. Variant interleukin 1 receptor antagonist gene alleles in sudden infant death syndrome. Arch Dis Child 2010; 95: 1009-12.
- 36. Machado JC, Pharoah P, Sousa S, Carvalho R, Oliveira C, Figueiredo C, et al. Interleukin 1B and interleukin 1RN polymorphisms are associated with increased risk of rastric carcinoma. Gastroenterology 2001; 121: 823-9.
- 37. Kutikhin AG. Impact of Toll-like receptor 4 polymorphisms on risk of cancer. Hum Immunol 2011; 72: 193-206.
- 38. Queiroz DM, Guerra JB, Rocha GA, Rocha AM, Santos A, De Oliveira AG, et al. IL1B and IL1RN polymorphic genes and Helicobacter pylori cagA strains decrease the risk of reflux esophagitis. Gastroenterology 2004; 127: 73-9.
- 39. Wu MS, Chen LT, Shun CT, Huang SP, Chiu HM, Wang HP, et al. Promoter polymorphisms of tumor necrosis factor-alpha are associated with risk of gastric mucosa-associated lymphoid tissue lymphoma. Int J Cancer 2004; 110: 695-700.
- 40. Garza-Gonzalez E, Bosques-Padilla FJ, El-Omar E, Hold G, Tijerina-Menchaca R, Maldonado-Garza HJ, et al. Role of the polymorphic IL-1B, IL-1RN and TNF-A genes in distal gastric cancer in Mexico. Int J Cancer 2005; 114: 237-41.
- 41. Achyut BR, Tripathi P, Ghoshal UC, Moorchung N, Mittal B. Interleukin-10 (-819 C/T) and tumor necrosis factor-alpha (-308 G/A) gene variants influence gastritis and lymphoid follicle development. Dig Dis Sci 2008; 53: 622-9.
- 42. Yea SS, Yang YI, Jang WH, Lee YJ, Bae HS, Paik KH. Association between TNF-alpha promotor polymorphism and Helicobacter pylori cagA subtype infection. J Clin Pathol 2001; 54: 703-6.
- 43. Tseng FC, Brown EE, Maiese EM, Yeager M, Welch R, Gold BD, et al. Polymorphisms in cytokine genes and risk of Helicobacter pylori infection among Jamaican children. Helicobacter 2006; 11: 425-30.
- 44. Chakravorty M, Datta De D, Choulhury A, Santra A, Roychoudhury S. Association of specific haplotype of TNFalpha with Helicobacter pylori-mediated duodenal ulcer in eastern Indian population. J Genet 2008; 87: 299-304.
- 45. Ando T, El-Omar EM, Goto Y, Nobata K, Watanabe O, Maeda O, et al. Interleukin 1B proinflammatory genotypes protect against gastro-oesophageal reflux disease through induction of corpus atrophy. Gut 2006; 55: 158-64.
- 46. Figueiredo C, Machado JC, Pharoah P, Seruca R, Sousa S, Carvalho R, et al. Helicobacter pylori and interleukin 1 genotyping: An opportunity to identify high-risk individuals for gastric carcinoma. J Natl Cancer Instit 2002; 94: 1680-7.